This work is licensed under the Creative Commons Attribution 4.0 International License.
Søndergaard Lars. Early Versus Later Re-valving in Tetralogy of Fallot with Free Pulmonary Regurgitation. 2019 May;(5th Edition). Available from: https://www.clinicaltrials.gov/ProvidedDocs/32/NCT04084132/Prot_SAP_000.pdfSearch in Google Scholar
Westhoff-Bleck M, Kornau F, Haghikia A, Horke A, Bertram H, Treptau J, et al. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation. Can J Cardiol. 2016 Oct;32(10):1247.e29-1247.e36.Search in Google Scholar
Villafañe J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, et al. Hot Topics in Tetralogy of Fallot. J Am Coll Cardiol. 2013 Dec;62(23):2155–66.Search in Google Scholar
Downing TE, Kim YY. Tetralogy of Fallot. Cardiol Clin. 2015 Nov;33(4):531–41.Search in Google Scholar
Bhagra CJ, Hickey EJ, Van De Bruaene A, Roche SL, Horlick EM, Wald RM. Pulmonary Valve Procedures Late After Repair of Tetralogy of Fallot: Current Perspectives and Contemporary Approaches to Management. Can J Cardiol. 2017 Sep;33(9):1138–49.Search in Google Scholar
Heng EL. Improved outcome prediction in tetralogy of Fallot. 2016 Dec [cited 2022 Jul 12]; Available from: http://spiral.imperial.ac.uk/handle/10044/1/50676Search in Google Scholar
Zegelbone PM, Ringel RE, Coulson JD, Nies MK, Stabler ME, Brown JR, et al. Heart failure biomarker levels correlate with invasive haemodynamics in pulmonary valve replacement. Cardiol Young. 2020 Jan;30(1):50–4.Search in Google Scholar
van der Ven JPG, van den Bosch E, Bogers AJCC, Helbing WA. Current outcomes and treatment of tetralogy of Fallot. F1000Research. 2019;8:F1000 Faculty Rev-1530.Search in Google Scholar
Nawaytou H, Bernstein HS. Biomarkers in pediatric heart disease. Biomark Med. 2014 Aug;8(7):943–63.Search in Google Scholar
Peng EWK, Spooner R, Young D, Danton MHD. Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot’s repair. Interact Cardiovasc Thorac Surg. 2012 Sep 1;15(3):335–9.Search in Google Scholar
Eindhoven JA, van den Bosch AE, Jansen PR, Boersma E, Roos-Hesselink JW. The Usefulness of Brain Natriuretic Peptide in Complex Congenital Heart Disease. J Am Coll Cardiol. 2012 Nov;60(21):2140–9.Search in Google Scholar
Jabagi H, Mielniczuk LM, Liu PP, Ruel M, Sun LY. Biomarkers in the Diagnosis, Management, and Prognostication of Perioperative Right Ventricular Failure in Cardiac Surgery—Are We There Yet? J Clin Med. 2019 Apr 25;8(4):559.Search in Google Scholar
Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev. 2014 Nov;19(6):727–42.Search in Google Scholar
Cantinotti M, Walters HL, Crocetti M, Marotta M, Murzi B, Clerico A. BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? Cardiol Young. 2015 Mar;25(3):424–37.Search in Google Scholar
S.E. Luijnenburg. Outcome Late After Repair of Tetralogy of Fallot [Internet]. Available from: https://repub.eur.nl/pub/40677/Search in Google Scholar
Dobson R, Walker HA, Walker NL. Biomarkers in congenital heart disease. Biomark Med. 2014 Aug;8(7):965–75.Search in Google Scholar
Willinger L, Brudy L, Meyer M, Oberhoffer-Fritz R, Ewert P, Müller J. Prognostic value of non-acute high sensitive troponin-T for cardiovascular morbidity and mortality in adults with congenital heart disease: A systematic review. J Cardiol. 2021 Sep;78(3):206–12.Search in Google Scholar
Hirono K, Sekine M, Shiba N, Hayashi S, Nakaoka H, Ibuki K, et al. N-terminal pro-Brain Natriuretic Peptide as a Predictor of Reoperation in Children With Surgically Corrected Tetralogy of Fallot. Circ J. 2014;78(3):693–700.Search in Google Scholar
Nir A, Luchner A, Rein AJ. The natriuretic peptides as biomarkers for adults with congenital heart disease. Biomark Med. 2012 Dec;6(6):827–37.Search in Google Scholar
Heng EL, Bolger AP, Kempny A, Davlouros PA, Davidson S, Swan L, et al. Neurohormonal activation and its relation to outcomes late after repair of tetralogy of Fallot. Heart. 2015 Mar 15;101(6):447–54.Search in Google Scholar
Paolino A, Hussain T, Pavon A, Velasco MN, Uribe S, Ordoñez A, et al. NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study. Pediatr Cardiol. 2017 Feb;38(2):324–31.Search in Google Scholar
Eindhoven JA, Menting ME, van den Bosch AE, Cuypers JAAE, Ruys TPE, Witsenburg M, et al. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol. 2014 Jul;174(3):550–6.Search in Google Scholar
Schoonbeek RC, Pieper PG, van Slooten YJ, Freling HG, Sieswerda GT, van Dijk APJ, et al. NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study. Neth Heart J. 2016 Nov;24(11):653–65.Search in Google Scholar
Baggen VJM, van den Bosch AE, Eindhoven JA, Schut ARW, Cuypers JAAE, Witsenburg M, et al. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease. Circulation. 2017 Jan 17;135(3):264–79.Search in Google Scholar
Rajpal S, Alshawabkeh L, Opotowsky AR. Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease. Curr Cardiol Rep. 2017 Jun;19(6):50.Search in Google Scholar
Yasukawa T, Hoashi T, Imai K, Okuda N, Fukuda T, Ohuchi H, et al. The reduced left ventricular stroke volume does not fully recover after pulmonary valve replacement in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg. 2021 Sep 11;60(3):526–33.Search in Google Scholar
Kitagawa A, Oka N, Kimura S, Ando H, Honda T, Takanashi M, et al. Clinical Utility of the Plasma Brain Natriuretic Peptide Level in Monitoring Tetralogy of Fallot Patients over the Long Term After Initial Intracardiac Repair: Considerations for Pulmonary Valve Replacement. Pediatr Cardiol. 2015 Apr;36(4):752–8.Search in Google Scholar
Kapoor PM, Subramanian A, Malik V, Kiran U, Velayoudham D. B-type natriuretic peptide as prognostic marker in tetralogy of Fallot surgery. Asian Cardiovasc Thorac Ann. 2015 Feb;23(2):146–52.Search in Google Scholar
Khokhar A, Zuhair M, Raj B, Heng EL, Alonso-Gonzalez R, Kempny A, et al. 2109Predictors of mortality following hospitalisation in adults with congenital heart disease. Eur Heart J [Internet]. 2018 Aug 1 [cited 2022 Aug 26];39(suppl_1). Available from: https://academic.oup.com/eurheartj/article/doi/10.1093/eurheartj/ehy565.2109/5082713Search in Google Scholar
Alborikan S, Von Klemperer K, Bhan A, Walker F, Pandya B, Badiani S, et al. Blood biomarkers in patients with repaired Tetralogy of Fallot (rTOF); A systematic review and meta-analysis. Int J Cardiol Congenit Heart Dis. 2021 Dec;6:100237.Search in Google Scholar